News

NextEra Just Secured Up to $1.9 Billion to Restart Iowa's Only Nuclear Plant. Here's The Real Reason Why.

Key PointsThe Department of Energy approved a loan of up to $1.9 billion to help NextEra Energy fund the restarting of Iowa's only nuclear plant.The company and the government tout

Source  The Motley Fool1788895501
Prediction: This Overlooked International ETF Will Outperform the S&P 500 Over the Next 20 Years

Key PointsVanguard’s forecasting model expects global stocks to outperform U.S. stocks for the next few decades -- perhaps by 1.2% to 2.2% per year.The Vanguard Total International

Source  The Motley Fool1788895200
Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund?

Key PointsiShares U.S. Pharmaceuticals ETF provides concentrated exposure to the pharmaceutical industry, while Invesco S&P 500 Equal Weight Health Care ETF offers broad healthcare

Source  The Motley Fool1788895141
Why Broadcom Stock Rallied Tuesday Morning

Key PointsBroadcom stock rallied following reports that Intel will raise prices.This gives other AI chipmakers cover to hike prices as well.10 stocks we like better than Broadcom ›

Source  The Motley Fool1788894897
1 No-Brainer ETF I'm Loading Up on in 2026 and Beyond

Key PointsThe Schwab U.S. Dividend Equity ETF's (SCHD) criteria act like a natural vetting process for investors.SCHD currently offers a dividend yield about three times that of an

Source  The Motley Fool1788893820
Is the iShares Pharmaceuticals ETF or iShares Healthcare ETF the Better Fund for 2026?

Key PointsiShares U.S. Pharmaceuticals ETF targets a specific subsector with 56 holdings, while iShares U.S. Healthcare ETF spans the broader industry with 100 holdings.iShares U.S

Source  The Motley Fool1788893401
Vistra Is Down 30% From Its High. Here's What I'd Do Now.

Key PointsVistra’s stock lost its “AI premium” over the past year.But that pullback represents a good buying opportunity for long-term investors.10 stocks we like better than Vistr

Source  The Motley Fool1788893400
SpaceX Stock Price Forecast: Nasdaq 100 Rebalancing May Trigger $12.4 Billion Passive Buying, Shares Could Rise to $161

TradingKey - On September 8 Eastern Time, SpaceX (SPCX)'s stock price broke through its intermediate high of $150, with technicals showing SpaceX's stock price is expected to break further above $161.

Source  Tradingkey1788893047
Performance Food Group Executive Hugh Patrick Hatcher Sells 3,000 Shares

Key PointsThe executive traded 3,000 shares for a total transaction value of ~$298,000 on September 1, 2026.The transaction size was ~5% of the shares held directly by the insider

Source  The Motley Fool1788892981
Carvana VP Stephen Palmer Sells 8,023 Shares

Key PointsThe disposition involved 8,023 shares with a total transaction value of ~$576,000 based on a weighted average price of $71.79.The activity represented 6% of the direct eq

Source  The Motley Fool1788892381
Broadcom vs. Marvell: Which Custom AI Chip Stock Is the Better Buy?

Key PointsMarvell Technology and Broadcom are growing at healthy rates, driven by rising demand for custom AI chips.Broadcom, however, has a larger market share in custom AI chips,

Source  The Motley Fool1788892260
Why SSR Mining Stock Surged 45% in August

Key PointsSSR Mining recently sold off its most troublesome asset. The gold miner is now flush with cash with no debt. SSR has also reinstated a dividend and is repurchasing shares

Source  The Motley Fool1788892075
Adobe's Next Earnings Report on Sept. 10 Could Send the Stock Plunging. Here's Why.

Key PointsAdobe is at a crossroads as AI reshapes its core business.Management has been focused on introducing its AI tools to the masses to acquire "the next generation of Adobe l

Source  The Motley Fool1788892043
Invesco Pharmaceuticals vs iShares Healthcare: Which Healthcare ETF Brings Better Profits

Key PointsiShares U.S. Healthcare ETF offers broader sector exposure with 100 holdings compared to the 27-stock pharmaceutical focus of Invesco Pharmaceuticals ETF.Invesco Pharmace

Source  The Motley Fool1788891628
2 Beaten-Down Stocks to Avoid Right Now

Key PointsTeladoc's business isn't making much progress, despite expanding insurance coverage within one of its most important segments. Recursion Pharmaceuticals claims that its a

Source  The Motley Fool1788891601
The CEO Fixing America's AI Infrastructure Lag Behind China

In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributor Rachel Warren talks with Hannan Happi, co-founder and CEO of Exowatt -- backed by Sam Altman and Andre

Source  The Motley Fool1788891601
CEO of TheFork Dumps 8,000 Company Shares as Tripadvisor Sells This Subsidiary

Key PointsThe transaction involved 8,000 shares executed at $9.45 per share on September 2, 2026, for a total value of $75,600.The sale involved shares equal to 21% of the executiv

Source  The Motley Fool1788891495
Why ServiceNow Stock Popped 33% Last Month

Key PointsServiceNow stock benefited from strong quarterly results from fellow enterprise software company Salesforce.AI is transforming the software industry, and ServiceNow share

Source  The Motley Fool1788891120
The Simple Reason I'm Not Worried About Nvidia's Hugging Face Acquisition

Key PointsNvidia's $12.9 billion acquisition of Hugging Face last week was its biggest ever.The deal gives it a valuable top-of-the-funnel platform in AI development.Even at $12.9

Source  The Motley Fool1788890701
Why IonQ Stock Jumped 12.4% This Morning

Key PointsIonQ issued five press releases ahead of its investor day, sending the stock as much as 12.4% higher.Management now expects 2026 revenue of $450 million to $460 million,

Source  The Motley Fool1788890208
Billionaire Stanley Druckenmiller Has 2 Megacap Stocks Worth Watching (Hint: His Top Holding Isn't Amazon, Alphabet, or Nvidia)

Key PointsStanley Druckemiller holds some smaller positions in Amazon and Alphabet. His largest stockholding is a company called Natera, which does DNA diagnostics. He has not owne

Source  The Motley Fool1788889800
The Earnings Report That Could Move the Market

In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Jon Quast, Matt Frankel, and Rachel Warren discuss:What to watch for during Nvidia's report on Wednes

Source  The Motley Fool1788888901
Forget Occidental Petroleum. Buy This Pipeline Stock in September Instead.

Key PointsWilliams is better insulated from volatile oil and gas prices than Oxy.Its focus on natural gas and BTM systems makes it a great AI infrastructure play.10 stocks we like

Source  The Motley Fool1788888900
Dollar Tree Director Stephanie Stahl Sells 1,185 Shares

Key PointsThe transaction involved 1,185 shares at $131.47 per share, representing a total value of ~$155,792 as of the September 4, 2026 transaction date.The shares traded represe

Source  The Motley Fool1788888001
3 Social Security Changes Beyond Your Monthly Check to Expect in 2027

Key PointsRetirees will likely get a cost of living adjustment in 2026.This change to your monthly check isn't the only change that's likely to happen.The amount needed to earn eli

Source  The Motley Fool1788888000
Bloom Energy Stock Price Forecast: Officially Joining S&P 500 on Sept. 21, Can Shares Break the Record High of $351?

TradingKey — On September 8, Eastern Time, Bloom Energy (BE) reclaimed the $280 mark after two months.S&P Dow Jones Indices announced last Friday that Bloom Energy will be officially added to the S&P

Source  Tradingkey1788887317
Move Aside, Pfizer: This Stock Is the Smarter Dividend Buy Right Now

Key PointsPharmaceutical giant AbbVie has a longer history of dividend growth than Pfizer.Pfizer faces greater exposure this decade to the loss of patent exclusivity for its blockb

Source  The Motley Fool1788887100
Taiwan Semiconductor Just Set a New Company Record. A New All-Time High Stock Price Is Coming

Key PointsTaiwan Semiconductor's gross margin just reached a new all-time high.TSMC's profits will continue soaring over the next few years thanks to AI. 10 stocks we like better t

Source  The Motley Fool1788886200
NuScale Power Stock Broke Out in August. Is It a Buy?

Key PointsNuScsale Power is still years away from deploying its first small modular nuclear reactor. The company, however, is flush with cash and is testing AI tools.10 stocks we l

Source  The Motley Fool1788885598
Is Novo Nordisk Stock Still Too Cheap for Investors to Ignore?

Key PointsNovo Nordisk was first to market with a GLP-1 weight-loss drug, but lost the lead to Eli Lilly.Novo Nordisk has been working hard to regain lost market share in the GLP-1

Source  The Motley Fool1788885300
goTop
quote